文献速递生殖医学母胎医学

PGT-A实验室分类策略与诊断产出及后续临床结局相关

Preimplantation genetic testing laboratory classification strategies are associated with diagnostic yield and downstream clinical performance.
PubMed 文献 · Fertil Steril · 2026-10-09

该回顾性队列研究分析了2015年至2023年间9630个PGT-A周期、40308枚囊胚的检测数据,涉及三家商业PGT-A实验室。结果显示,不同实验室的整倍体率和单整倍体胚胎移植活产率存在差异,实验室B与实验室A相比活产率更低(OR=0.71),提示整倍体率不能单独作为实验室性能的完整指标。

要点

  • 不同PGT-A实验室的整倍体率随母亲年龄变化存在差异。
  • 实验室B与实验室A相比,单整倍体胚胎移植活产率显著更低(OR=0.71)。
  • 整倍体率与下游活产率不一致,需结合临床结局评估实验室性能。

核心结论

  • PGT-A实验室分类策略与诊断产出及单整倍体胚胎移植活产率均相关。
  • 整倍体率与活产率之间的不一致表明,仅凭整倍体率不能全面衡量实验室性能。

研究设计与样本

  • 涉及三家商业PGT-A实验室:实验室A(n=18480)、实验室B(n=19261)、实验室C(n=2567)。
  • 临床结局分析限于网络主诊所进行的7333例单整倍体胚胎移植。

主要发现

  • 总体囊胚整倍体率为52.3%(21093/40308)。
  • 与实验室A相比,实验室B在年轻患者中整倍体率及获得至少一枚整倍体胚胎的可能性更低,但在年龄>42岁患者中整倍体率更高。
  • 实验室C在年龄<41岁患者中诊断产出持续较低。
  • 7333例单整倍体胚胎移植的活产率分别为实验室A 49.8%、实验室B 41.6%、实验室C 50.7%。
  • 调整母亲年龄、BMI、不孕指征、内膜准备和厚度、胚胎评级及活检日后,实验室B与实验室A相比活产几率更低(OR=0.71,95%CI:0.64-0.79;p<0.001),实验室C与实验室A相当(OR=1.08,95%CI:0.89-1.32;p=0.418)。

临床怎么用

  • 选择PGT-A实验室时不应仅关注整倍体率,需结合单整倍体胚胎移植后的活产率等下游临床结局综合评估。
  • 对于不同年龄患者,实验室分类策略对诊断产出的影响可能不同,临床解读结果时应考虑年龄因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether PGT-A laboratory was associated with diagnostic yield and live birth per single euploid embryo transfer. DESIGN: Retrospective cohort study. SUBJECTS: We analyzed a total of 9,630 PGT-A cycles performed between January 2015 and December 2023, comprising 40,308 blastocysts tested using trophectoderm biopsy and next generation sequencing. Three commercial PGT-A laboratories were utilized: Laboratory A (n = 18,480), Laboratory B (n = 19,261), and Laboratory C (n = 2,567). Clinical outcome analyses were restricted to 7,333 single euploid embryo transfers performed at the network's main clinic. EXPOSURE: PGT-A laboratory. MAIN OUTCOME MEASURES: Euploidy rate, likelihood of having at least one euploid embryo available for transfer, and live birth rate per single euploid embryo transfer. RESULTS: Overall, 52.3% (21,093/40,308) of blastocysts were diagnosed as euploid. Diagnostic yield differed between laboratories and varied according to maternal age. Compared with Laboratory A, Laboratory B had lower euploidy rates and a lower likelihood of obtaining at least one euploid embryo in younger patients, with higher euploidy rates observed among patients aged >42 years. Laboratory C had a consistently lower diagnostic yield in patients younger than 41 years. Among 7,333 single euploid embryo transfers performed at the main clinic, live birth rates per transfer were 49.8%, 41.6%, and 50.7% for Laboratories A, B, and C, respectively. After adjusting for maternal age, BMI, infertility indication, endometrial preparation and thickness, embryo grade, and biopsy day, Laboratory B remained associated with lower odds of live birth per single euploid embryo transfer compared to Laboratory A (OR=0.71, [95%CI: 0.64-0.79]; p<0.001), while Laboratory C was comparable (OR=1.08, [95%CI: 0.89-1.32]; p=0.418). CONCLUSION: PGT-A laboratory classification strategy was associated with both diagnostic yield and live birth per transfer. The discordance between these outcomes shows that euploidy rates alone do not provide a complete measure of laboratory performance and should be interpreted alongside downstream clinical outcomes.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Popovic M, Kalafat E, Sakkas D, et al. Preimplantation genetic testing laboratory classification strategies are associated with diagnostic yield and downstream clinical performance. Fertil Steril. 2026. PMID: 42854774. doi:10.1016/j.fertnstert.2026.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。